Automated Device Safety Surveillance Gets Proof Of Principle

Comprehensively tracking post-market safety signals presents an almost insurmountable challenge for the limited staff in FDA's device center. But a new automated computer surveillance system should be able to provide needed assistance, scientists from CDRH, Harvard University and other institutions say.

More from Archive

More from Medtech Insight